ARCHIVES

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

This article is from The Cancer Letter archive.

Vol. 06 No. 24 | June 13, 1980

Download PDF Visit The Full Archive

Related Articles

Ford Gets Temporary Funds Bill; House Committee Demands More Positions for NCI

June 27, 1975

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013